Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Angiogenesis regulation via exerkines" does not refer to a single molecule or receptor but rather describes the process by which **exerkines**—a diverse group of humoral factors released in response to acute or chronic exercise—modulate the formation of new blood vessels. Exerkines include cytokines, peptides, and metabolites secreted from skeletal muscle and other organs during physical activity. Notable examples are interleukin‑6 (IL‑6) and fibroblast growth factor 21 (FGF21), both shown to influence metabolic adaptation, tissue regeneration, and vascular remodeling. For instance, FGF21 sensitivity in cardiac tissue is increased by endurance exercise, promoting myocardial angiogenesis and protecting against ischemic injury. The term itself is not a canonical target but an umbrella for multiple molecular mediators involved in exercise-induced physiological responses related to vascular health[1][2][3].
Exerkines act as messengers released during exercise that can promote or regulate the formation of new blood vessels (angiogenesis) in various tissues by modulating signaling pathways such as FGF21/FGF receptor/KLB axis and IL‑6/GLP‑1 axis[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis regulation via exerkines.